Overview
Legal name
ACURABLE LIMITED
Region
London
Registered address
83 VICTORIA STREET
LONDON
ENGLAND
SW1H 0HW
Insolvency history
No
Company
Active
LTD
Company profile
Acurable Limited
Acurable | Wearable Medical Devices
We create accurate and user friendly wearable medical devices intended to be used by patients at home
CRN
10310661
Founded
2016
Age
9
Company events
Reference milestones and recent Companies House filing stream events.
8 events
30 Sep
2026
Accounts due
Accounts DueNext accounts due date
08 Sep
2026
Confirmation statement due
Confirmation DueNext confirmation statement due date
25 Aug
2025
Confirmation statement filed
ConfirmationLast confirmation statement made up date
31 Dec
2024
Accounts filed
AccountsLast accounts made up date
15 Nov
2024
Capital Allotment Shares
CapitalSH01 | Transaction MzQ0MzU5NDcyMGFkaXF6a2N4
Published 15 Nov 2024 05:25
04 Sep
2024
Accounts With Accounts Type Small
Accounts Awaiting analysisAA | Transaction MzQzNDUwNTA3MGFkaXF6a2N4
Published 04 Sep 2024 15:00
30 Aug
2024
Confirmation Statement With Updates
Confirmation-statementCS01 | Transaction MzQzMzk3MjEwMmFkaXF6a2N4
Published 30 Aug 2024 13:44
03 Aug
2016
Incorporated
InceptionCompany registered at Companies House
Public funding
4 awards
First funded
2019
Funded years
2019, 2020, 2022
Age at first award
2 years
Projects
2022
Collaborative R&D
Lead participant
Automatic identification of cardiorespiratory biomarkers for remote management of chronic conditions
1 Oct 2022 to 31 Mar 2024
Awarded
£350,000
Total cost £500,000
Early detection of clinical deterioration in patients can help reduce admissions to intensive care units (ICUs), cardiac arrests, sepsis, and deaths. Deteriorations commonly manifest themselves early via very subtle changes in body signals, such as those directly generated by cardiac and respiratory functions. Accurately measuring those signals and comput...
2020
Feasibility Studies
Lead participant
A wearable technology for diagnosing sleep apnoea in children - COVID19 Continuity Grant
1 Jun 2020 to 31 Mar 2021
Awarded
£198,817
Total cost £284,024
no public description
2019
Collaborative R&D
Lead participant
A wearable technology for diagnosing sleep apnoea in children
1 Jul 2019 to 30 Jun 2022
Awarded
£820,925
Total cost £1,172,750
Acurable produces the first truly wearable medical device able to accurately diagnose sleep apnoea in a non-invasive way. Acurable's patented technology is a major engineering innovation and the product of 10 years research at Imperial College London. Our solution uses a non-invasive wearable sensor (AcuPebble) to monitor acoustic signals of the patient a...
2019
Collaborative R&D
Lead participant
Diagnosing Sleep Apnoea At Home with a Novel Wearable Technology
1 Jan 2019 to 31 Dec 2020
Awarded
£349,880
Total cost £499,829
Acurable produces the first truly wearable medical device able to accurately diagnose sleep apnoea in a non-invasive way. Acurable's patented technology is a major engineering innovation and the product of 10 years research at Imperial College London. Our solution uses a non-invasive wearable sensor (AcuPebble) to monitor acoustic signals of the patient a...
Product types
Collaborative R&D
Feasibility Studies